AGP Executive Report
Last update: 8 hours agoOphthalmology Pipeline Update: Oculis will take part in the Piper Sandler Virtual Ophthalmology Conference, highlighting late-stage work including Privosegtor for optic neuritis and Licaminlimab for dry eye disease—both aimed at unmet neuro-ophthalmic and eye-care needs. Rare-Disease Access in Iceland: SERB Pharmaceuticals says it has completed acquisition of EU/UK/NO/CH and Iceland rights to Idefirix (imlifidase), a time-critical transplant medicine, with EU approval conditional on a post-authorization study now fulfilled. Biotech Funding in Reykjavik: Alvotech secured an additional $75m term loan facility (plus earlier equity), bringing access to $240m total to support biosimilar R&D and product launches. Pet Care Warning: The UK’s RSPCA warns pet owners are increasingly using AI chatbots for symptom checks instead of vets, raising safety and legal concerns if animals go untreated. Cross-Border Healthcare Basics: A guide explains how healthcare across European borders works—who can use it, what costs may be covered, and when prior authorisation applies. Whaling & Animal Welfare: Iceland’s renewed commercial whaling is reported alongside claims of animal welfare violations, with campaigners pushing for stronger enforcement and a whaling ban. Nutrition for Everyday Wellness: A dietitian shares a high-fiber, high-protein breakfast formula using oats, Skyr/strained yogurt, and fiber-rich toppings—built for consistency without boredom.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
